Plasma cell disorders

Macrophage Inhibitory Factor-1 (MIF-1) controls the plasticity of multiple myeloma tumor cells

Danielle Joseph, Jason P. Gonsky, Stacy W. Blain

Dietary intake is associated with risk of multiple myeloma and its precursor disease

Marianna Thordardottir, Ebba K. Lindqvist, [ ... ], Sigurdur Y. Kristinsson

A simple approach for multi-targeted shRNA-mediated inducible knockdowns using Sleeping Beauty vectors

Severin Fink, Laurens Zugelder, [ ... ], Thorsten Stühmer

Prognostic utility of serum free light chain ratios and heavy-light chain ratios in multiple myeloma in three PETHEMA/GEM phase III clinical trials

Lucia Lopez-Anglada, Cecilia Cueto-Felgueroso, [ ... ], on behalf of the GEM (Grupo Español de MM)/PETHEMA (Programa para el Estudio de la Terapéutica en Hemopatías Malignas) Cooperative Study Group

Body composition measurements and risk of hematological malignancies: A population-based cohort study during 20 years of follow-up

Hannes Hagström, Anna Andreasson, [ ... ], Mattias Carlsten

The metabolomic plasma profile of myeloma patients is considerably different from healthy subjects and reveals potential new therapeutic targets

Normann Steiner, Udo Müller, [ ... ], Eberhard Gunsilius

MALDI-TOF analysis of blood serum proteome can predict the presence of monoclonal gammopathy of undetermined significance

Francisca Barceló, Rosa Gomila, [ ... ], José Portugal

The phosphoinositide-3 kinase (PI3K)-δ,γ inhibitor, duvelisib shows preclinical synergy with multiple targeted therapies in hematologic malignancies

Kerrie Faia, Kerry White, [ ... ], Jeffery Kutok

Impact of IFN lambda 3/4 single nucleotide polymorphisms on the cytomegalovirus reactivation in autologous stem cell transplant patients

Ombretta Annibali, Livia Piccioni, [ ... ], Elisabetta Riva

ARQ-197, a small-molecule inhibitor of c-Met, reduces tumour burden and prevents myeloma-induced bone disease in vivo

Darren L. Lath, Clive H. Buckle, [ ... ], Andrew D. Chantry

Low expression of neural cell adhesion molecule, CD56, is associated with low efficacy of bortezomib plus dexamethasone therapy in multiple myeloma

Takashi Yoshida, Masaki Ri, [ ... ], Shinsuke Iida

Real life management of patients hospitalized with multiple myeloma in France

Charles Dumontet, Sandrine Couray-Targe, [ ... ], Delphine Maucort-Boulch

Role of serum immunoglobulins for predicting sarcoidosis outcome: A cohort study

Nicolas Belhomme, Stéphane Jouneau, [ ... ], Patrick Jégo

Plasma cell disorders

Connect with Us